Hexagon Bio

Hexagon

This biotechnology company develops small-molecule therapeutics and antibody-drug conjugate payloads for patients with cancer and infectious diseases.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Heidelberg Pharma

This biopharmaceutical company develops antibody drug conjugates for cancer treatment, serving pharmaceutical partners and patients through its proprietary toxin-based technology platform.

CrossBridge Bio

This company develops dual-payload antibody-drug conjugates to treat solid tumors for healthcare providers and pharmaceutical partners.

Pheon Therapeutics

The company develops antibody-drug conjugates to treat solid tumours for the healthcare and pharmaceutical sectors.

Bead Biopharma

This company develops chemical platform technologies to improve the stability and performance of antibody-drug conjugates for pharmaceutical developers and cancer researchers.

Heidelberg Pharma AG

This biopharmaceutical company develops antibody-drug conjugates for oncology patients using proprietary toxin technology to target and eliminate cancer cells.

Catena Bio

This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.